Despite all the uncertainty right now, one thing is definite: the date for Fachpack 2021. The European trade fair for packaging, technology and processing will take place as planned at the Exhibition Centre Nuremberg from 28 to 30 September 2021.
A new rPET extrusion system will be going into operation in early May 2020 at the recycling plant PET Recycling Team in Radomsko (Poland). As a result, the capacity for rPET (PET regrind material) will be doubled from 15,000 to 30,000 tonnes per annum.
The current SARS-CoV-2 / COVID-19-pandemic has underscored it once again: protecting sensitive, vital products remains the key contribution that packaging solutions make to sustainability.
Packaging company Scanfill is adjusting the production for a brand new market. The company will produce up to half a million face shields together with Plast Petter AB - every week.
Utilize opportunities for economic reconstruction. More independence for Europe in raw materials procurement.
PolyOne announced the launch of ColorMatrix Amosorb 4020G, a non-nylon based, low-haze oxygen scavenger for polyethylene terephthalate (PET) rigid packaging.
In the corona crisis, packaging is playing an important role in helping to supply people with food, medicines and PPE. And more than ever, its most important characteristic – its protective function – is coming to the fore.
thyssenkrupp’s plant engineering business has won a second order from the Turkish packaging producer Köksan for a new PET production plant. The plant will be built next to an existing production line erected in 2013.
Chinaplas is further postponed. It will probably be held next April.
According to business magazine Forbes, around 140 PET bottles per head are circulated in Europe each year, with this figure more than twice that in the USA at 290.
The 2020 trade fair year has so far, due to the coronavirus, been characterised by postponements and cancellations. The interpack, too, has had to be rescheduled to February 2021 to protect the people involved and to slow the spread of Covid-19.
Medical cannabis is increasingly becoming a topic of interest for doctors and society as an alternative therapy for serious diseases. From the perspective of drug manufacturers this development brings new possibilities, but also great challenges.
